Utrecht/WHO Collaborating Centre for

Pharmaceutical Policy and Regulation

PhD Programme

Background
The Utrecht Centre for Pharmaceutical Policy and Regulation (scientific director: prof.dr. H.G.M. Leufkens) offers an international high quality PhD-programme for professionals with several years of relevant work experience. The unique format of the programme combines academic research and public health practice requiring candidates to use their work experience, data and policy issues as input for their PhD-thesis. The Utrecht Centre is a leading platform for independent multidisciplinary research which links drug regulation, pharmacoepidemiology, public health and policy analysis. The Centre is based at the Division of Pharmacoepidemiology and Clinical Pharmacology of Utrecht University in the Netherlands, an internationally acclaimed research institute, and works closely with the WHO Department of Essential Medicines and Pharmaceutical Policies (EMP) in Geneva, Switzerland. The Division also has strong ties with many other partners at the national and international level.

Research Themes
The work of the Centre concentrates on the design and evaluation of pharmaceutical policies with a focus on Global Health, Drug Regulatory Science and Governance/Ethics. Work of the applicant should be in this field. Applicants with (research) experience in Drug Regulation and Governance/Ethics are especially invited to apply. As of October 2016, 27 professional PhDs are enrolled in the programme. A list of all participants can be find here.

More information
Please read the flyer to learn more about the programme, what we offer and what type of candidates we are looking for: PhD programme professionals 2017

Application
The application to enrol for October 2017 is open now. Please send all required document before 1 June 2017 to Dr. Rianne van den Ham, h.a.vandenham@.uu.nl. You can use the following checklist to make sure your application is complete: Checklist PhD programme 2017.